Consolidated Statements of Changes In Equity - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Redeemable Perpetual Preferred  Stock	Distributions in Excess of Accumulated Earnings	Accumulated Other Comprehensive Income (Loss)	Non- Controlling Interests – Common OP Units
Beginning balance at Dec. 31, 2021	$ 1,486,171	$ 1,913	$ 1,593,362	$ 0	$ (183,689)	$ 3,524	$ 71,061
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exchange of Common OP Units for Common Stock	0		312				(312)
Issuance of Common Stock through employee stock purchase plan	2,743		2,743
Issuance of Common Stock	28,370	3	28,367
Compensation expenses related to restricted stock and stock options	10,537		10,537
Repurchase of Common Stock or Common OP Units	(3,449)		(3,449)
Adjustment for Common OP Unitholders in the Operating Partnership	0		(2,357)				2,357
Adjustment for fair market value of swap	15,595					15,595
Consolidated net income	298,825			16	284,611		14,198
Distributions	(320,410)			(16)	(305,170)		(15,224)
Other	(897)		(897)
Ending balance at Dec. 31, 2022	1,517,485	1,916	1,628,618	0	(204,248)	19,119	72,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exchange of Common OP Units for Common Stock	0	1	1,237				(1,238)
Issuance of Common Stock through employee stock purchase plan	1,983		1,983
Compensation expenses related to restricted stock and stock options	14,711		14,711
Repurchase of Common Stock or Common OP Units	(1,932)		(1,932)
Adjustment for Common OP Unitholders in the Operating Partnership	0		(20)				20
Adjustment for fair market value of swap	(13,058)					(13,058)
Consolidated net income	329,677			16	314,191		15,470
Distributions	(349,967)			(16)	(333,519)		(16,432)
Other	(278)		(278)
Ending balance at Dec. 31, 2023	1,498,621	1,917	1,644,319	0	(223,576)	6,061	69,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exchange of Common OP Units for Common Stock	0		6				(6)
Issuance of Common Stock through employee stock purchase plan	1,790		1,790
Issuance of Common Stock	317,387	45	317,342
Compensation expenses related to restricted stock and stock options	6,702		6,702
Repurchase of Common Stock or Common OP Units	(1,908)		(1,908)
Adjustment for Common OP Unitholders in the Operating Partnership	0		(12,761)				12,761
Adjustment for fair market value of swap	(3,758)					(3,758)
Consolidated net income	384,818			16	366,998		17,804
Distributions	(375,806)			(16)	(358,401)		(17,389)
Other	(4,060)		(4,060)
Ending balance at Dec. 31, 2024	$ 1,823,786	$ 1,962	$ 1,951,430	$ 0	$ (214,979)	$ 2,303	$ 83,070